MarginsXMarginsX
Home › Markets › NNBXF

Nanobiotix S.A. (NNBXF)

NNBXF is quoted over the counter, not listed on an exchange. Nanobiotix S.A. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close
No daily closes stored yet
1-year return
No daily closes stored yet
Market cap
No stored closes, so no market cap
P/E and P/S
No stored closes

Profile

FieldValue
TickerNNBXF, quoted over the counter
SEC CIK0001760854
SEC industry codePharmaceutical Preparations
Business addressParis, France
Incorporated inFrance

Warning signs

Cash runway
18.9 months
52.8M EUR cash at December 31, 2025
Share count, 1 year
+2.1%
2024-12-31 to 2025-12-31 · +38.8% over 3 years
Going-concern doubt
No
20-F filed March 31, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"Accordingly, Management has determined there is no substantial doubt regarding the Company's ability to continue as a going concern."
20-F 2026-03-31
Cash and burn52.8M EUR cash; operating cash flow -8.4M EUR a quarter.Report 2025-12-31
Shares outstanding48,410,068 (2025-12-31); 47,426,851 a year earlier; 34,875,872 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-05-22
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG SA, Paris La Défense, FrancePCAOB Form AP 2026-05-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
32.6M EUR-24.0M EUR-33.4M EUR52.8M EURNo debt tags32.6M EUR20-F 2026-03-31
FY 2024
2024-12-31
-7.2M EUR-68.1M EUR-19.6M EUR49.7M EURNo debt tags-7.2M EUR20-F 2026-03-31
FY 2023
2023-12-31
36.2M EUR-39.7M EUR-12.5M EUR75.3M EURNo debt tags36.2M EUR20-F 2026-03-31
FY 2022
2022-12-31
4.8M EUR-57.0M EUR-37.1M EUR41.4M EURNo debt tags4.8M EUR20-F 2025-04-02
FY 2021
2021-12-31
2.6M EUR-47.1M EUR-29.9M EUR83.9M EURNo debt tags2.6M EUR20-F 2024-04-24
FY 2020
2020-12-31
2.5M EUR-33.6M EUR-27.5M EUR119.2M EURNo debt tags2.5M EUR20-F 2023-04-24
FY 2019
2019-12-31
2.5M EUR-50.9M EUR-41.2M EUR35.1M EURNo debt tags2.5M EUR20-F 2022-04-08
FY 2018
2018-12-31
3.5M EUR-30.3M EUR-26.0M EUR36.2M EURNo debt tags3.5M EUR20-F/A 2021-04-08

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in EUR.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-05-22
Latest annual report20-F2026-03-31
Latest quarterly / interim6-K2026-11-12

Source: SEC EDGAR submissions feed, 313 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier